Daniel J Mitchell insider trades: ARCA biopharma (ABIO) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Daniel reports to the SEC
Open-market buys and sales
40 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 2, 2017 | ABIO | ↑ Buy | 11,000 | $2.71 | $30K | Direct | May 3, 2017 (1d) |
| Mar 17, 2016 | GBIM | ↓ Sell | 21,330 | $1.66 | $35K | By Sequel Limited Partnership III | Mar 18, 2016 (1d) |
| Mar 17, 2016 | GBIM | ↓ Sell | 270 | $1.66 | $448 | By Sequel Entrepreneurs Fund III, LP | Mar 18, 2016 (1d) |
| Mar 15, 2016 | GBIM | ↓ Sell | 127,493 | $2.26 | $288K | By Sequel Limited Partnership III | Mar 15, 2016 (0d) |
| Mar 15, 2016 | GBIM | ↓ Sell | 2,776 | $2.28 | $6K | By Sequel Entrepreneurs Fund III, LP | Mar 15, 2016 (0d) |
| Mar 10, 2016 | GBIM | ↓ Sell | 15,957 | $1.17 | $19K | By Sequel Limited Partnership III | Mar 10, 2016 (0d) |
| Mar 10, 2016 | GBIM | ↓ Sell | 443 | $1.17 | $518 | By Sequel Entrepreneurs Fund III, LP | Mar 10, 2016 (0d) |
| Mar 7, 2016 | GBIM | ↓ Sell | 11,598 | $1.05 | $12K | By Sequel Limited Partnership III | Mar 7, 2016 (0d) |
| Mar 7, 2016 | GBIM | ↓ Sell | 322 | $1.05 | $338 | By Sequel Entrepreneurs Fund III, LP | Mar 7, 2016 (0d) |
| Mar 2, 2016 | GBIM | ↓ Sell | 16,951 | $1.02 | $17K | By Sequel Limited Partnership III | Mar 2, 2016 (0d) |
| Mar 2, 2016 | GBIM | ↓ Sell | 471 | $1.02 | $482 | By Sequel Entrepreneurs Fund III, LP | Mar 2, 2016 (0d) |
| Feb 26, 2016 | GBIM | ↓ Sell | 12,163 | $1.03 | $13K | By Sequel Limited Partnership III | Feb 26, 2016 (0d) |
| Feb 26, 2016 | GBIM | ↓ Sell | 338 | $1.03 | $349 | By Sequel Entrepreneurs Fund III, LP | Feb 26, 2016 (0d) |
| Feb 23, 2016 | GBIM | ↓ Sell | 22,240 | $1.42 | $32K | By Sequel Limited Partnership III | Feb 23, 2016 (0d) |
| Feb 23, 2016 | GBIM | ↓ Sell | 618 | $1.42 | $879 | By Sequel Entrepreneurs Fund III, LP | Feb 23, 2016 (0d) |
| Feb 18, 2016 | GBIM | ↓ Sell | 21,306 | $1.45 | $31K | By Sequel Limited Partnership III | Feb 18, 2016 (0d) |
| Feb 18, 2016 | GBIM | ↓ Sell | 591 | $1.45 | $854 | By Sequel Entrepreneurs Fund III, LP | Feb 18, 2016 (0d) |
| Feb 12, 2016 | GBIM | ↓ Sell | 3,547 | $1.75 | $6K | By Sequel Limited Partnership III | Feb 12, 2016 (0d) |
| Feb 12, 2016 | GBIM | ↓ Sell | 98 | $1.74 | $171 | By Sequel Entrepreneurs Fund III, LP | Feb 12, 2016 (0d) |
| Feb 9, 2016 | GBIM | ↓ Sell | 7,102 | $2.05 | $15K | By Sequel Limited Partnership III | Feb 9, 2016 (0d) |
| Feb 9, 2016 | GBIM | ↓ Sell | 198 | $2.05 | $406 | By Sequel Entrepreneurs Fund III, LP | Feb 9, 2016 (0d) |
| Jul 8, 2014 | GBIM | ↑ Buy | 75,000 | $10.00 | $750K | By Sequel Limited Partnership III | Jul 9, 2014 (1d) |
| Jul 8, 2014 | GBIM | ↑ Buy | 10,000 | $10.00 | $100K | Direct | Jul 9, 2014 (1d) |
| Dec 12, 2008 | RDYN | ↑ Buy | 10,000 | $0.75 | $7K | By The Daniel J. Mitchell Trust | Dec 16, 2008 (4d) |
| Dec 11, 2008 | RDYN | ↑ Buy | 19,260 | $0.69 | $13K | By The Daniel J. Mitchell Trust | Dec 12, 2008 (1d) |
| Dec 3, 2008 | RDYN | ↑ Buy | 42,695 | $0.64 | $27K | By The Daniel J. Mitchell Trust | Dec 4, 2008 (1d) |
| Sep 14, 2006 | RDYN | ↑ Buy | 560 | $9.97 | $6K | By The Daniel J. Mitchell Trust | Sep 15, 2006 (1d) |
| Sep 13, 2006 | RDYN | ↑ Buy | 400 | $9.93 | $4K | By The Daniel J. Mitchell Trust | Sep 14, 2006 (1d) |
| Sep 12, 2006 | RDYN | ↑ Buy | 500 | $10.30 | $5K | By The Daniel J. Mitchell Trust | Sep 13, 2006 (1d) |
| Sep 11, 2006 | RDYN | ↑ Buy | 1,000 | $10.00 | $10K | By The Daniel J. Mitchell Trust | Sep 12, 2006 (1d) |
| Sep 8, 2006 | RDYN | ↑ Buy | 1,911 | $9.75 | $19K | By The Daniel J. Mitchell Trust | Sep 11, 2006 (3d) |
| Sep 7, 2006 | RDYN | ↑ Buy | 2,300 | $9.66 | $22K | By The Daniel J. Mitchell Trust | Sep 8, 2006 (1d) |
| Aug 11, 2006 | RDYN | ↑ Buy | 1,230 | $10.05 | $12K | By The Daniel J. Mitchell Trust | Aug 11, 2006 (0d) |
| Aug 10, 2006 | RDYN | ↑ Buy | 6,037 | $10.09 | $61K | By The Daniel J. Mitchell Trust | Aug 11, 2006 (1d) |
| Aug 9, 2006 | RDYN | ↑ Buy | 2,733 | $10.09 | $28K | By The Daniel J. Mitchell Trust | Aug 10, 2006 (1d) |
| May 23, 2006 | MYOG | ↑ Buy | 2,000 | $29.56 | $59K | By the Dan J. Mitchell Trust dated 10/2/ | May 24, 2006 (1d) |
| Mar 13, 2006 | MYOG | ↑ Buy | 3,000 | $35.79 | $107K | By the Dan J. Mitchell Trust dated 10/2/ | Mar 14, 2006 (1d) |
| Aug 22, 2005 | MYOG | ↑ Buy | 1,500 | $20.98 | $31K | By the Dan J. Mitchell Trust dated 10/2/ | Aug 24, 2005 (2d) |
| Jul 6, 2005 | MYOG | ↑ Buy | 5,000 | $7.15 | $36K | By the Dan J. Mitchell Trust dated 10/2/ | Jul 7, 2005 (1d) |
| Jun 29, 2005 | MYOG | ↑ Buy | 6,000 | $6.71 | $40K | By the Dan J. Mitchell Trust dated 10/2/ | Jun 30, 2005 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Daniel J Mitchell's insider trades
Daniel J Mitchell is a director at ARCA biopharma (ABIO). Since Jun 29, 2005, Daniel has reported 20 open-market purchases worth $1.4M and 20 sales worth $478K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (14 filings), other transactions (6 filings), conversions (2 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ABIO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.